Abstract:

ABSTRACT A middle-aged male was admitted for nephritic syndrome, and diagnosed membranous nephropathy（MN）by renal biopsy of native kidney as well as phospholipase A2 receptor (PLA2R) antibody positive. There was no secondary available factor. Graft biopsy-proven recurrent MN developed at 5 months post-transplant. The levels of proteiniura and serum PLA2R antibody were decreased after the treatment of rituximab.
Key words

Key words: renal transplantation, membranous nephropathy, phospholipase A2 receptor(PLA2R) antibodies, rituximab